{
    "organizations": [],
    "uuid": "860889a2cef36d22792e7f72b80b905c2eab449a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/csl-outlook/australias-csl-lifts-full-year-profit-outlook-idUSL3N1SO60C",
    "ord_in_thread": 0,
    "title": "Australia's CSL lifts full-year profit outlook",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 18 (Reuters) - Biotherapeutics company CSL Ltd on Friday lifted its full-year profit guidance for a second time this year, thanks to better-than-expected product sales.\nCSL now expects net profit after tax for fiscal 2018 in the range of about $1.68 billion to $1.71 billion, from an earlier forecast of $1.55 billion to $1.60 billion, it said in a statement. (Reporting by Chris Thomas in Bengaluru Editing by Leslie Adler)\n ",
    "published": "2018-05-18T06:49:00.000+03:00",
    "crawled": "2018-05-18T19:29:47.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "biotherapeutics",
        "company",
        "csl",
        "ltd",
        "friday",
        "lifted",
        "profit",
        "guidance",
        "second",
        "time",
        "year",
        "thanks",
        "product",
        "sale",
        "csl",
        "expects",
        "net",
        "profit",
        "tax",
        "fiscal",
        "range",
        "billion",
        "billion",
        "earlier",
        "forecast",
        "billion",
        "billion",
        "said",
        "statement",
        "reporting",
        "chris",
        "thomas",
        "bengaluru",
        "editing",
        "leslie",
        "adler"
    ]
}